← FDA Drug Approvals (Drugs@FDA)

CYTALUX

NDA · New Drug Application · Sponsor: ON TARGET LABS · Approved 2021-11-29

Drug application

FDA Application #

NDA214907

Application type

New Drug Application

Brand name

CYTALUX

Generic name

PAFOLACIANINE INJECTION

Active ingredients

PAFOLACIANINE SODIUM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ON TARGET LABS

Manufacturer

On Target Laboratories, Inc.

First approval

2021-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown